Neuroscientific Biopharmaceuticals (ASX:NSB) Ending Cash Position : A$3.34 Mil (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Neuroscientific Biopharmaceuticals Ending Cash Position?

Neuroscientific Biopharmaceuticals's Ending Cash Position for the quarter that ended in Dec. 2023 was A$3.34 Mil.

Neuroscientific Biopharmaceuticals's quarterly Ending Cash Position increased from Dec. 2022 (A$3.33 Mil) to Jun. 2023 (A$4.91 Mil) but then declined from Jun. 2023 (A$4.91 Mil) to Dec. 2023 (A$3.34 Mil).

Neuroscientific Biopharmaceuticals's annual Ending Cash Position declined from Jun. 2021 (A$14.16 Mil) to Jun. 2022 (A$7.22 Mil) and declined from Jun. 2022 (A$7.22 Mil) to Jun. 2023 (A$4.91 Mil).

Neuroscientific Biopharmaceuticals Ending Cash Position Historical Data

The historical data trend for Neuroscientific Biopharmaceuticals's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuroscientific Biopharmaceuticals Ending Cash Position Chart

Neuroscientific Biopharmaceuticals Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

Ending Cash Position

4.61

3.29

14.16

7.22

4.91

Neuroscientific Biopharmaceuticals Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Ending Cash Position	Get a 7-Day Free Trial							9.50	7.22	3.33	4.91	3.34

Neuroscientific Biopharmaceuticals Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Neuroscientific Biopharmaceuticals's Ending Cash Position for the fiscal year that ended in Jun. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	7.216	+	-2.304
	=	4.91

Neuroscientific Biopharmaceuticals's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	4.911	+	-1.575
	=	3.34

Neuroscientific Biopharmaceuticals Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Neuroscientific Biopharmaceuticals's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Neuroscientific Biopharmaceuticals (ASX:NSB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neuroscientific Biopharmaceuticals Ltd (ASX:NSB) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

85 Forrest Street, Suite 5, Cottesloe, Perth, WA, AUS, 6011

Website

https://www.neuroscientific.com

Neuroscientific Biopharmaceuticals Ltd is an Australian-based biotechnology company. The company is engaged in the development of diagnostic and therapeutic treatments for neurodegenerative diseases through preclinical studies of patented technologies.

Neuroscientific Biopharmaceuticals (ASX:NSB) Headlines

No Headlines